Repeat Ivermectin Mass Drug Administrations for Malaria Control II (RIMDAMAL II): Primary Outcome from the Cluster-Randomized Control Trial Article Swipe
Anyirékun Fabrice Somé
,
Anthony Somé
,
Emmanuel Sougue
,
Cheick Oumar W. Ouédraogo
,
Ollo Da
,
Rodrigue Dah
,
Frédéric Nikièma
,
Tereza Magalhães
,
Lyndsey Gray
,
Will Finical
,
Greg Pugh
,
Paula Lado
,
Jenna C. Randall
,
Timothy A. Burton
,
Molly E. Ring
,
A. I. León
,
McKenzie Colt
,
Fangyong Li
,
Kaicheng Wang
,
Martina Wade
,
Audun Lier
,
Kacey Richards
,
Hannah Sproch
,
Elizabeth Zhang
,
Julia Ellman
,
Ijeamaka Achebe
,
Conner Jackson
,
Mengli Xiao
,
Emma J. Wu
,
Teun Bousema
,
Hannah Slater
,
Brian D. Foy
,
Sunil Parikh
,
Roch K. Dabiré
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2139/ssrn.4938033
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2139/ssrn.4938033
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- http://doi.org/10.2139/ssrn.4938033
- OA Status
- green
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4401994758
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4401994758Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2139/ssrn.4938033Digital Object Identifier
- Title
-
Repeat Ivermectin Mass Drug Administrations for Malaria Control II (RIMDAMAL II): Primary Outcome from the Cluster-Randomized Control TrialWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-01Full publication date if available
- Authors
-
Anyirékun Fabrice Somé, Anthony Somé, Emmanuel Sougue, Cheick Oumar W. Ouédraogo, Ollo Da, Rodrigue Dah, Frédéric Nikièma, Tereza Magalhães, Lyndsey Gray, Will Finical, Greg Pugh, Paula Lado, Jenna C. Randall, Timothy A. Burton, Molly E. Ring, A. I. León, McKenzie Colt, Fangyong Li, Kaicheng Wang, Martina Wade, Audun Lier, Kacey Richards, Hannah Sproch, Elizabeth Zhang, Julia Ellman, Ijeamaka Achebe, Conner Jackson, Mengli Xiao, Emma J. Wu, Teun Bousema, Hannah Slater, Brian D. Foy, Sunil Parikh, Roch K. DabiréList of authors in order
- Landing page
-
https://doi.org/10.2139/ssrn.4938033Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.2139/ssrn.4938033Direct OA link when available
- Concepts
-
Ivermectin, Mass drug administration, Randomized controlled trial, Cluster (spacecraft), Malaria, Medicine, Drug, Cluster randomised controlled trial, Internal medicine, Pharmacology, Environmental health, Immunology, Veterinary medicine, Computer science, Population, Programming languageTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4401994758 |
|---|---|
| doi | https://doi.org/10.2139/ssrn.4938033 |
| ids.doi | https://doi.org/10.2139/ssrn.4938033 |
| ids.openalex | https://openalex.org/W4401994758 |
| fwci | |
| type | preprint |
| title | Repeat Ivermectin Mass Drug Administrations for Malaria Control II (RIMDAMAL II): Primary Outcome from the Cluster-Randomized Control Trial |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11702 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9789999723434448 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Parasitic Diseases Research and Treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777499811 |
| concepts[0].level | 2 |
| concepts[0].score | 0.813803493976593 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q415178 |
| concepts[0].display_name | Ivermectin |
| concepts[1].id | https://openalex.org/C2780133432 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7252033948898315 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q6784028 |
| concepts[1].display_name | Mass drug administration |
| concepts[2].id | https://openalex.org/C168563851 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6499228477478027 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[2].display_name | Randomized controlled trial |
| concepts[3].id | https://openalex.org/C164866538 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6063607335090637 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q367351 |
| concepts[3].display_name | Cluster (spacecraft) |
| concepts[4].id | https://openalex.org/C2778048844 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5752529501914978 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12156 |
| concepts[4].display_name | Malaria |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.5283067226409912 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C2780035454 |
| concepts[6].level | 2 |
| concepts[6].score | 0.48358839750289917 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[6].display_name | Drug |
| concepts[7].id | https://openalex.org/C176400912 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4231260418891907 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3058662 |
| concepts[7].display_name | Cluster randomised controlled trial |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.31331244111061096 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C98274493 |
| concepts[9].level | 1 |
| concepts[9].score | 0.24837106466293335 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[9].display_name | Pharmacology |
| concepts[10].id | https://openalex.org/C99454951 |
| concepts[10].level | 1 |
| concepts[10].score | 0.23743224143981934 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[10].display_name | Environmental health |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.15519332885742188 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C42972112 |
| concepts[12].level | 1 |
| concepts[12].score | 0.15226274728775024 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q170201 |
| concepts[12].display_name | Veterinary medicine |
| concepts[13].id | https://openalex.org/C41008148 |
| concepts[13].level | 0 |
| concepts[13].score | 0.07844015955924988 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[13].display_name | Computer science |
| concepts[14].id | https://openalex.org/C2908647359 |
| concepts[14].level | 2 |
| concepts[14].score | 0.0678587257862091 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[14].display_name | Population |
| concepts[15].id | https://openalex.org/C199360897 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q9143 |
| concepts[15].display_name | Programming language |
| keywords[0].id | https://openalex.org/keywords/ivermectin |
| keywords[0].score | 0.813803493976593 |
| keywords[0].display_name | Ivermectin |
| keywords[1].id | https://openalex.org/keywords/mass-drug-administration |
| keywords[1].score | 0.7252033948898315 |
| keywords[1].display_name | Mass drug administration |
| keywords[2].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[2].score | 0.6499228477478027 |
| keywords[2].display_name | Randomized controlled trial |
| keywords[3].id | https://openalex.org/keywords/cluster |
| keywords[3].score | 0.6063607335090637 |
| keywords[3].display_name | Cluster (spacecraft) |
| keywords[4].id | https://openalex.org/keywords/malaria |
| keywords[4].score | 0.5752529501914978 |
| keywords[4].display_name | Malaria |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.5283067226409912 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/drug |
| keywords[6].score | 0.48358839750289917 |
| keywords[6].display_name | Drug |
| keywords[7].id | https://openalex.org/keywords/cluster-randomised-controlled-trial |
| keywords[7].score | 0.4231260418891907 |
| keywords[7].display_name | Cluster randomised controlled trial |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.31331244111061096 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/pharmacology |
| keywords[9].score | 0.24837106466293335 |
| keywords[9].display_name | Pharmacology |
| keywords[10].id | https://openalex.org/keywords/environmental-health |
| keywords[10].score | 0.23743224143981934 |
| keywords[10].display_name | Environmental health |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.15519332885742188 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/veterinary-medicine |
| keywords[12].score | 0.15226274728775024 |
| keywords[12].display_name | Veterinary medicine |
| keywords[13].id | https://openalex.org/keywords/computer-science |
| keywords[13].score | 0.07844015955924988 |
| keywords[13].display_name | Computer science |
| keywords[14].id | https://openalex.org/keywords/population |
| keywords[14].score | 0.0678587257862091 |
| keywords[14].display_name | Population |
| language | en |
| locations[0].id | doi:10.2139/ssrn.4938033 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210172589 |
| locations[0].source.issn | 1556-5068 |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1556-5068 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | SSRN Electronic Journal |
| locations[0].source.host_organization | https://openalex.org/I1318003438 |
| locations[0].source.host_organization_name | RELX Group (Netherlands) |
| locations[0].source.host_organization_lineage | https://openalex.org/I1318003438 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | http://doi.org/10.2139/ssrn.4938033 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5018877466 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1530-1493 |
| authorships[0].author.display_name | Anyirékun Fabrice Somé |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Anyirékun F. Some |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5086450969 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Anthony Somé |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Anthony Somé |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5039558110 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9974-0671 |
| authorships[2].author.display_name | Emmanuel Sougue |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Emmanuel Sougue |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5091615153 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Cheick Oumar W. Ouédraogo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Cheick Oumar W. Ouédraogo |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5058486937 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6319-5322 |
| authorships[4].author.display_name | Ollo Da |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ollo Da |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5106808815 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Rodrigue Dah |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Rodrigue Dah |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5036706486 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6226-9230 |
| authorships[6].author.display_name | Frédéric Nikièma |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Frederic Nikièma |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5076424795 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1474-0889 |
| authorships[7].author.display_name | Tereza Magalhães |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Tereza Magalhæs |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5034724566 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5897-464X |
| authorships[8].author.display_name | Lyndsey Gray |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Lyndsey I. Gray |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5106808811 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Will Finical |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Will Finical |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5112047424 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-2826-3131 |
| authorships[10].author.display_name | Greg Pugh |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Greg Pugh |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5046512609 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-4852-3495 |
| authorships[11].author.display_name | Paula Lado |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Paula Lado |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5071413218 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Jenna C. Randall |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Jenna C. Randall |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5102858229 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-7135-2543 |
| authorships[13].author.display_name | Timothy A. Burton |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Timothy A. Burton |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5113355409 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Molly E. Ring |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Molly E. Ring |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5055405584 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | A. I. León |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Anna-Sofia Leon |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5032715784 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-7141-1179 |
| authorships[16].author.display_name | McKenzie Colt |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | McKenzie Colt |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5089282370 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-3171-7592 |
| authorships[17].author.display_name | Fangyong Li |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Fangyong Li |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5115589873 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Kaicheng Wang |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Kaicheng Wang |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5039557556 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-2898-1296 |
| authorships[19].author.display_name | Martina Wade |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Martina Wade |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5066299320 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-7548-4140 |
| authorships[20].author.display_name | Audun Lier |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Audun Lier |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5023907373 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-5624-9791 |
| authorships[21].author.display_name | Kacey Richards |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Kacey Richards |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5106808812 |
| authorships[22].author.orcid | |
| authorships[22].author.display_name | Hannah Sproch |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Hannah Sproch |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5088182347 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-1117-8635 |
| authorships[23].author.display_name | Elizabeth Zhang |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Elizabeth Zhang |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5106808813 |
| authorships[24].author.orcid | |
| authorships[24].author.display_name | Julia Ellman |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Julia Ellman |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5106808814 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | Ijeamaka Achebe |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Ijeamaka Achebe |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5005046500 |
| authorships[26].author.orcid | https://orcid.org/0000-0002-3519-5667 |
| authorships[26].author.display_name | Conner Jackson |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Conner Jackson |
| authorships[26].is_corresponding | False |
| authorships[27].author.id | https://openalex.org/A5104075449 |
| authorships[27].author.orcid | https://orcid.org/0000-0003-4974-3588 |
| authorships[27].author.display_name | Mengli Xiao |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Mengli Xiao |
| authorships[27].is_corresponding | False |
| authorships[28].author.id | https://openalex.org/A5109771775 |
| authorships[28].author.orcid | |
| authorships[28].author.display_name | Emma J. Wu |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Emma J. Wu |
| authorships[28].is_corresponding | False |
| authorships[29].author.id | https://openalex.org/A5036396443 |
| authorships[29].author.orcid | https://orcid.org/0000-0003-2666-094X |
| authorships[29].author.display_name | Teun Bousema |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Teun Bousema |
| authorships[29].is_corresponding | False |
| authorships[30].author.id | https://openalex.org/A5051642189 |
| authorships[30].author.orcid | https://orcid.org/0000-0003-4291-7899 |
| authorships[30].author.display_name | Hannah Slater |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Hannah Slater |
| authorships[30].is_corresponding | False |
| authorships[31].author.id | https://openalex.org/A5041825501 |
| authorships[31].author.orcid | https://orcid.org/0000-0002-9117-203X |
| authorships[31].author.display_name | Brian D. Foy |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Brian D. Foy |
| authorships[31].is_corresponding | False |
| authorships[32].author.id | https://openalex.org/A5041011585 |
| authorships[32].author.orcid | https://orcid.org/0000-0001-9411-5180 |
| authorships[32].author.display_name | Sunil Parikh |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | Sunil Parikh |
| authorships[32].is_corresponding | False |
| authorships[33].author.id | https://openalex.org/A5059548173 |
| authorships[33].author.orcid | https://orcid.org/0000-0002-3471-3506 |
| authorships[33].author.display_name | Roch K. Dabiré |
| authorships[33].author_position | last |
| authorships[33].raw_author_name | Roch K. Dabiré |
| authorships[33].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.2139/ssrn.4938033 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Repeat Ivermectin Mass Drug Administrations for Malaria Control II (RIMDAMAL II): Primary Outcome from the Cluster-Randomized Control Trial |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11702 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9789999723434448 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Parasitic Diseases Research and Treatment |
| related_works | https://openalex.org/W2112227588, https://openalex.org/W2104543391, https://openalex.org/W2784700003, https://openalex.org/W2067933750, https://openalex.org/W4297140377, https://openalex.org/W2886427597, https://openalex.org/W2969392661, https://openalex.org/W2560592171, https://openalex.org/W4393969877, https://openalex.org/W2031370719 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.2139/ssrn.4938033 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210172589 |
| best_oa_location.source.issn | 1556-5068 |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1556-5068 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | SSRN Electronic Journal |
| best_oa_location.source.host_organization | https://openalex.org/I1318003438 |
| best_oa_location.source.host_organization_name | RELX Group (Netherlands) |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1318003438 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.2139/ssrn.4938033 |
| primary_location.id | doi:10.2139/ssrn.4938033 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210172589 |
| primary_location.source.issn | 1556-5068 |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1556-5068 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | SSRN Electronic Journal |
| primary_location.source.host_organization | https://openalex.org/I1318003438 |
| primary_location.source.host_organization_name | RELX Group (Netherlands) |
| primary_location.source.host_organization_lineage | https://openalex.org/I1318003438 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | http://doi.org/10.2139/ssrn.4938033 |
| publication_date | 2024-01-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 34 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7900000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.21080623 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |